BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6247274)

  • 1. Complement-dependent antiviral monospecific antibody-mediated lysis of murine cells coated with Sendai virus or its envelope component.
    Hosaka Y; Fukami Y; Yasuda Y; Bonilla JA
    Infect Immun; 1980 Feb; 27(2):355-63. PubMed ID: 6247274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T-lymphocyte reactivity with individual Sendai virus glycoproteins.
    Al-Ahdal MN; Nakamura I; Flanagan TD
    J Virol; 1985 Apr; 54(1):53-7. PubMed ID: 2983119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of a virus membrane protein into the lipid bilayer of target cells as a prerequisite for immune cytolysis. Specific cytolysis after virosome-target cell fusion.
    Morein B; Barz D; Koszinowski U; Schirrmacher V
    J Exp Med; 1979 Dec; 150(6):1383-98. PubMed ID: 512589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-liposome modification of target cells as a method to alter their susceptibility to lysis by cytotoxic T lymphocytes.
    Hale AH; Ruebush MJ; Lyles DS; Harris DT
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6105-8. PubMed ID: 6255476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies.
    Orvell C; Rydbeck R; Löve A
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of fusion activity of ultraviolet light-inactivated Sendai virus in formation of target antigens recognized by cytotoxic T cells.
    Sugamura K; Shimizu K; Bach FH
    J Exp Med; 1978 Jul; 148(1):276-87. PubMed ID: 78960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoelectron microscopic study on interactions of noninfectious sendai virus and murine cells.
    Yasuda Y; Hosaka Y; Fukami Y; Fukai K
    J Virol; 1981 Jul; 39(1):273-81. PubMed ID: 6268815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some physico-chemical and biological properties of egg-Sendai virus with altered haemagglutinin-neuraminidase protein.
    Popa LM; Repanovici R; Iliescu R; Mihalache O; Cajal N
    Acta Virol; 1985 Dec; 29(6):461-5. PubMed ID: 2869656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HVJ (Sendai virus)-induced envelope fusion and cell fusion are blocked by monoclonal anti-HN protein antibody that does not inhibit hemagglutination activity of HVJ.
    Miura N; Uchida T; Okada Y
    Exp Cell Res; 1982 Oct; 141(2):409-20. PubMed ID: 6291960
    [No Abstract]   [Full Text] [Related]  

  • 10. Activation of complement by antibodies to the keratosulphate-like host antigen of Sendai virus.
    Fadnes P; Haukenes G
    Acta Pathol Microbiol Scand C; 1980 Apr; 88(2):73-6. PubMed ID: 6247879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing activity of the antibodies against two kinds of envelope glycoproteins of Sendai virus.
    Tozawa H; Komatsu H; Ohkata K; Nakajima T; Watanabe M; Tanaka Y; Arifuku M
    Arch Virol; 1986; 91(1-2):145-61. PubMed ID: 2428330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoproteins of Sendai virus: purification and antigenic analysis.
    Urata DM; Seto JT
    Intervirology; 1975-1976; 6(2):108-14. PubMed ID: 58850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in capacity of Sendai virus envelope components to induce cytotoxic T lymphocytes in primary and secondary immune responses.
    Fukami Y; Hosaka Y; Yasuda Y; Bonilla JA
    Infect Immun; 1979 Dec; 26(3):815-21. PubMed ID: 231009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein.
    Markwell MA; Portner A; Schwartz AL
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):978-82. PubMed ID: 2983337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus.
    Portner A; Scroggs RA; Metzger DW
    Virology; 1987 May; 158(1):61-8. PubMed ID: 2437698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Component(s) of Sendai virus that can induce interferon in mouse spleen cells.
    Ito Y; Hosaka Y
    Infect Immun; 1983 Mar; 39(3):1019-23. PubMed ID: 6301988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elicitation of anti-Sendai virus cytotoxic T lymphocytes by viral and H-2 antigens incorporated into the same lipid bilayer by membrane fusion and by reconstitution into liposomes.
    Hale AH; Lyles DS; Fan DP
    J Immunol; 1980 Feb; 124(2):724-31. PubMed ID: 6243330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
    Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated cytotoxicity against targets bearing Sendai virus glycoproteins in the absence of viral infection.
    Abidi TF; Flanagan TD
    J Virol; 1984 May; 50(2):380-6. PubMed ID: 6323738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization.
    Vasantha S; Coelingh KL; Murphy BR; Dourmashkin RR; Hammer CH; Frank MM; Fries LF
    Virology; 1988 Dec; 167(2):433-41. PubMed ID: 2849234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.